More on AGEN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.25 |
|
|||
| Open | $3.25 | ||||
| 52 Wk High | $7.49 | ||||
| 52 Wk Low | $2.61 | ||||
| Day High | $3.25 | ||||
| Day Low | $3.25 | ||||
| P/E | N/A | ||||
| EPS | $-1.10 | ||||
| Volume | 178 | ||||
- Form 4 AGENUS INC For: Jul 01 Filed by: HARRISON THOMAS L
- Form 4 AGENUS INC For: Jul 01 Filed by: Wright Timothy
- Form 8-K AGENUS INC For: Jun 29
- Agenus reports 3-year survival data for colorectal cancer drug combo
- Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026
- Form 4 AGENUS INC For: Jun 26 Filed by: ARMEN GARO H
- Agenus to present 3-year colorectal cancer survival data at ESMO GI
- Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026
- Form 8-K AGENUS INC For: Jun 16
- Form 4 AGENUS INC For: Jun 12 Filed by: ARMEN GARO H
Entities mentioned with AGEN
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
